The Research Council of Norway has now introduced a portfolio management model which means that investments are structured along fewer and more coordinated areas with their own portfolio boards. Each portfolio board has prepared a preliminary portfolio plan which forms the basis for the Research Council’s total investments within its area. These plans were prepared on the basis of existing program plans. These plans will now be revised.
The HEALTH portfolio comprises a wide range of research and innovation projects, from outstanding open research on the international front via applied research to meet societal challenges, to research and innovation for the development of a competitive health industry.
The Faculty of Medicine is invited to provide input to the portfolio plan through two input phases:
Input phase 1 – The knowledge base
In the first input phase, the purpose is to capture trends that are important as a knowledge base for the plan. A dialogue meeting has been held with the Faculty of Medicine. The challenges were:
- Which trends in society and research constitute a particularly important knowledge base for the portfolio plan for health?
- What are the most important societal challenges the portfolio plan for health must help to meet?
- What do questions 1 and 2 entail for prioritizing research topics, subjects and type of research / innovation?
K2 invited the research group leaders some weeks ago to provide input, and we have collected these and forwarded them to the Faculty. The result was that the Faculty out forward the following:
- Personalized medicine
- Global Health
- Research in the primary health care service
Input phase 2 – Draft portfolio plan
The second input phase is an online hearing in December 2021 where the Research Council invites everyone who is interested to provide input to the portfolio plan. After this input phase, the portfolio plan will be presented to the portfolio board and later for approval by the Research Council’s board in June 2022.
For information, there is a preliminary portfolio plan on the Research Council’s website for the portfolio, Porteføljeplan for Helse (forskningsradet.no)
Enjoy the week-end!
Trial lecture: June 10th, at 09.15
Subject: “Helseeffekter av fysisk aktivitet og trening hos eldre kvinner og menn”
Dissertation: 1June 10th at 11:00
Title: “Exercise Training in Patients with Chronic Heart Failure on Optimal Medical Therapy”
- opponent: Dr.med. Einar Gude, Rikshospitalet, Oslo Universitetssykehus
- opponent: Professor Maja Lisa Løchen, Norges arktiske universitet
- medlem av komiteen: Professor emeritus Jon Arne Søreide, Universitetet i Bergen
Custos: professor emeritus Dennis Nilsen
Open for all.
For Professors, researchers and young talents
Do you know of young research talents abroad that you would like to bring to your lab?
Are you a young talent who would like to boost your career with an international stay?
Then you should consider the Marie Sklodowska Curie Postdoctoral Fellowship progra mme.
The goal of MSCA Postdoctoral Fellowships (formerly, Individual Fellowships) is to enhance the creative and innovative potential of researchers holding a PhD, wishing to acquire new skills through advanced training, international, interdisciplinary and inter-sectoral mobility.
Applicants must have been awarded their doctoral degree within 8 years prior to the deadline of the call. Exceptions: career breaks.
Postdoctoral Fellowships either can take place in Europe (i.e. in an EU Member State or a Horizon Europe Associated Country like Norway) or in a Third Country not associated to Horizon Europe (e.g. USA):
- European Postdoctoral Fellowships: Fellows (any nationality) either come to Europe from any country in the world or move within Europe for a project. The standard duration of these fellowships must be between 12 and 24 months.
- Global Postdoctoral Fellowships: European nationals or long-term residents who wish to engage in projects with organisations outside EU Member States and Horizon Europe Associated Countries. These fellowships require an outgoing phase of minimum 12 and maximum 24 months in a non-associated Third Country, and a mandatory 12-month return phase to a host organisation based in an EU Member State or a Horizon Europe Associated Country.
Deadline 15 Sept. 2021
If you have any questions, please do not hesitate to contact email@example.com.